Clinical Trial Detail

NCT ID NCT04061590
Title Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Cisplatin + Pembrolizumab + Pemetrexed Disodium

Age Groups: adult senior

No variant requirements are available.